logo
Webb telescope smashed a record with the planet it just discovered

Webb telescope smashed a record with the planet it just discovered

Yahoo4 days ago
Given that Saturn is nearly 100 times more massive than Earth, it seems like a joke to refer to an exoplanet of the same weight as "light."
But that's what NASA and the European Space Agency, one of its partners on the James Webb Space Telescope, have called a world their observatory just discovered. Found 111 light-years away in space, the young planet is only about 6 million years old — a mere babe in cosmic terms. A wide ring of dust surrounds it in TWA 7, its star system in the Air Pump constellation.
With the Webb telescope's powerful infrared camera, scientists spotted what was pushing around that debris: a faint object at least 10 times lighter than the previous planets discovered through direct imaging.
The detection, which still must be confirmed through additional observations, represents the lightest planet ever seen with this technique outside the solar system, and it marks a major milestone in the search for exoplanets obscured by debris disks — those wide, dusty belts left behind after planets begin to form. Researchers say Webb's sharper vision and deeper sensitivity mean smaller, colder, and more distant planets are finally within reach.
"This observatory enables us to capture images of planets with masses similar to those in the solar system, which represents an exciting step forward in our understanding of planetary systems, including our own," said Mathilde Malin of Johns Hopkins University in Baltimore, in a statement.
SEE ALSO: Scientists just expanded the search for rocky alien worlds with air
The James Webb Space Telescope captured a suspected exoplanet's thermal glow. Credit: NASA GSFC / CIL / Adriana Manrique Gutierrez illustration
This exoplanet, dubbed TWA 7b, sits about 52 times farther from its star than Earth is from the sun. That places it right in the middle of a gap in the dust — the kind of thing scientists expect when a planet sculpts the debris around it with its gravity.
Telescopes of the past weren't sensitive enough to spot such a small, faint planet so close to a bright star, but Webb captured its thermal glow with its mid-infrared instrument. Scientists then checked old existing images and data to rule out other possible explanations, like a background star, galaxy, or even a distant solar system object like a dwarf planet that happened to be in the same part of the sky. Nothing else fit. The discovery team published their findings in the journal Nature.
Webb usually observes exoplanets through indirect methods, such as transmission spectroscopy, a technique for studying a planet's atmosphere by analyzing how starlight filters through it. What distinguishes this observation of TWA 7b is that the telescope captured light from the planet itself.
The discovery comes on the heels of Webb's direct image of two previously known larger gas giants, YSES-1b and YSES-1c, about 300 light-years from Earth. The research revealed one of the exoplanets has sand-like clouds while the other is surrounded by moon-making material.
Few distant worlds meet the criteria for direct imaging because planets are often millions of times fainter than the stars they circle. And if they are orbiting close, their own light usually gets washed out. But scientists want these images because they allow scientists to get much more information about an exoplanet's composition.
The James Webb Space Telescope snapped a direct image of the TWA 7 star system, which includes a suspected exoplanet labeled CC #1, with its mid-infrared instrument. To the far left is an unrelated star system. Credit: NASA / ESA / CSA / Anne-Marie Lagrange et al. / https://doi.org/10.1038/s41586-025-09150-4doi.org/10.1038/s41586-025-09150-4
Molecules within a planet's atmosphere absorb certain colors of light, so when astronomers study a planet's spectrum, they can look for what's missing from the rainbow to determine which gases — like water, methane, and carbon dioxide — are present in the planet's air.
"TWA 7b is suited for direct spectroscopic investigations, providing the opportunity to study the interior and the atmosphere of a non-irradiated sub-Jupiter-mass, cold exoplanet, and start comparative studies with our much older and cooler solar system giants," the authors wrote.
Scientists overcame the challenge of the star, sometimes known as CE Antilae, by blocking its light with a special telescope instrument called a coronagraph. This device suppressed the red dwarf star's bright glare. The technique allows astronomers to see planets that would otherwise be swamped out. After subtracting excess starlight using advanced image processing, the faint infrared source from TWA 7b emerged.
Computer models showed that a Saturn-size planet with a temperature of about 120 degrees Fahrenheit would match what Webb saw. The simulations were also consistent with the way the dust ring is shaped, including the seemingly "empty" area around the candidate planet's location.
Ongoing studies of the distant world will aim to better nail down its properties and confirm it is indeed a planet.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

GeoVax Highlights Critical Role of Multi-Antigen COVID-19 Vaccines as Nimbus Variant Underscores Persistent and Evolving Public Health Threat
GeoVax Highlights Critical Role of Multi-Antigen COVID-19 Vaccines as Nimbus Variant Underscores Persistent and Evolving Public Health Threat

Associated Press

time41 minutes ago

  • Associated Press

GeoVax Highlights Critical Role of Multi-Antigen COVID-19 Vaccines as Nimbus Variant Underscores Persistent and Evolving Public Health Threat

With COVID-19 continuing to mutate and over 40 million immunocompromised Americans still at risk, GeoVax's GEO-CM04S1 vaccine offers potential broader, more durable protection through a unique multi-antigen approach ATLANTA, GA - July 3, 2025 ( NEWMEDIAWIRE ) - GeoVax Labs, Inc. (Nasdaq: GOVX), a clinical-stage biotechnology company developing multi-antigen vaccines and immunotherapies, today emphasized the urgent need for innovation in COVID-19 vaccination as the NB.1.8.1 variant - commonly known as 'Nimbus' - spreads rapidly across the globe. Nimbus, a highly transmissible Omicron subvariant classified by the World Health Organization as a 'Variant Under Monitoring,' is now dominant in multiple U.S. states and surging across Europe and Asia. Though not more severe, its rapid spread and potential for immune escape reflect an increasingly clear reality: COVID-19 is not going away, and it will continue to evolve. 'The emergence of the Nimbus variant is a stark reminder that we need 'smarter' vaccines, not just newer ones,' said David Dodd, Chairman and CEO of GeoVax. 'Our GEO-CM04S1 vaccine was designed for this purpose and is built to potentially provide broader and longer-lasting protection, especially for the immunocompromised patients most at risk.' GEO-CM04S1: Multi-Antigen Protection for the Immunocompromised Unlike mRNA vaccines that rely solely on the Spike protein, GEO-CM04S1 delivers both Spike (S) and Nucleocapsid (N) antigens, stimulating an immune response that includes not only an antibody response, but also robust T-cell activity. This is believed to be critical for cross-variant protection and extended durability, particularly in individuals with weakened immune systems. GEO-CM04S1 is currently being evaluated in two Phase 2 clinical trials, focused on populations at greatest risk from COVID-19 complications, including blood cancer patients scheduled to receive stem cell transplant therapy. In one of the ongoing Phase 2 trials, the mRNA control arm was discontinued due to poor immunogenicity with the remainder of the trial only including GEO-CM04S1 which surpassed the immunogenicity target, reinforcing the limitations of monovalent vaccines and the important value of a multi-antigen vaccine approach in such high-risk patient populations. 'There are more than 40 million immunocompromised individuals in the U.S. alone,' said Dodd. 'They are underserved by the current, FDA-approved vaccine options that deliver only an antibody response and require a better solution with both breadth and longevity of protection.' Public Vaccine Policy and Regulatory Changes Support Platform Diversification Recent guidance from the U.S. Food and Drug Administration (FDA) calls for diversified vaccine platforms and risk-based regulatory pathways. Additionally, the CDC's narrowed 2025–2026 booster recommendations - now focused on adults 65+ and immunocompromised individuals - closely mirror GeoVax's clinical strategy and target population. GEO-CM04S1 has been proposed under BARDA's Rapid Response Partnership Vehicle (RRPV) for surge manufacturing support and integration into long-term public health preparedness efforts. The proposal, 'Innovation in Clinical Manufacturing of MVA-Vectored COVID-19 Vaccines', was selected by the RRPV, pending funding availability. 'As public health moves toward more targeted, durable, and inclusive vaccination strategies, GEO-CM04S1 is positioned to deliver where first generation COVID-19 vaccines fall short,' Dodd added. In addition to targeting today's variants, GEO-CM04S1 is structurally designed to adapt to future mutations and serve as a platform for multi-pathogen preparedness. As part of GeoVax's broader MVA-based portfolio, the platform underpins vaccine candidates for Mpox, smallpox, and hemorrhagic fever viruses, offering scale and flexibility across infectious disease threats. About GeoVax GeoVax Labs, Inc. is a clinical-stage biotechnology company developing novel vaccines against infectious diseases and therapies for solid tumor cancers. The Company's lead clinical program is GEO-CM04S1, a next-generation COVID-19 vaccine currently in three Phase 2 clinical trials, being evaluated as (1) a primary vaccine for immunocompromised patients such as those suffering from hematologic cancers and other patient populations for whom the current authorized COVID-19 vaccines are insufficient, (2) a booster vaccine in patients with chronic lymphocytic leukemia (CLL) and (3) a more robust, durable COVID-19 booster among healthy patients who previously received the mRNA vaccines. In oncology the lead clinical program is evaluating a novel oncolytic solid tumor gene-directed therapy, Gedeptin(R), having recently completed a multicenter Phase 1/2 clinical trial for advanced head and neck cancers. GeoVax is also developing a vaccine targeting Mpox and smallpox and, based on recent regulatory guidance, anticipates progressing directly to a Phase 3 clinical evaluation, omitting Phase 1 and Phase 2 trials. GeoVax has a strong IP portfolio in support of its technologies and product candidates, holding worldwide rights for its technologies and products. For more information about the current status of our clinical trials and other updates, visit our website: Forward-Looking Statements This release contains forward-looking statements regarding GeoVax's business plans. The words 'believe,' 'look forward to,' 'may,' 'estimate,' 'continue,' 'anticipate,' 'intend,' 'should,' 'plan,' 'could,' 'target,' 'potential,' 'is likely,' 'will,' 'expect' and similar expressions, as they relate to us, are intended to identify forward-looking statements. We have based these forward-looking statements largely on our current expectations and projections about future events and financial trends that we believe may affect our financial condition, results of operations, business strategy and financial needs. Actual results may differ materially from those included in these statements due to a variety of factors, including whether: GeoVax is able to obtain acceptable results from ongoing or future clinical trials of its investigational products, GeoVax's immuno-oncology products and preventative vaccines can provoke the desired responses, and those products or vaccines can be used effectively, GeoVax's viral vector technology adequately amplifies immune responses to cancer antigens, GeoVax can develop and manufacture its immuno-oncology products and preventative vaccines with the desired characteristics in a timely manner, GeoVax's immuno-oncology products and preventative vaccines will be safe for human use, GeoVax's vaccines will effectively prevent targeted infections in humans, GeoVax's immuno-oncology products and preventative vaccines will receive regulatory approvals necessary to be licensed and marketed, GeoVax raises required capital to complete development, there is development of competitive products that may be more effective or easier to use than GeoVax's products, GeoVax will be able to enter into favorable manufacturing and distribution agreements, and other factors, over which GeoVax has no control. Further information on our risk factors is contained in our periodic reports on Form 10-Q and Form 10-K that we have filed and will file with the SEC. Any forward-looking statement made by us herein speaks only as of the date on which it is made. Factors or events that could cause our actual results to differ may emerge from time to time, and it is not possible for us to predict all of them. We undertake no obligation to publicly update any forward-looking statement, whether as a result of new information, future developments or otherwise, except as may be required by law. Company Contact: [email protected] 678-384-7220 Investor Relations Contact: [email protected] 212-698-8696 Media Contact: Jessica Starman [email protected]

Is there a launch today? Upcoming SpaceX, NASA, ULA rocket launch schedule at Cape Canaveral
Is there a launch today? Upcoming SpaceX, NASA, ULA rocket launch schedule at Cape Canaveral

Yahoo

timean hour ago

  • Yahoo

Is there a launch today? Upcoming SpaceX, NASA, ULA rocket launch schedule at Cape Canaveral

During the first six months of the year, an array of 56 orbital rockets took flight from Florida's Space Coast. This unpreceded pace will zoom beyond 2024's freshly established annual record of 93 launches — should the cadence continue through year's end. Will a new launch record materialize at Cape Canaveral Space Force Station and NASA's neighboring Kennedy Space Center? Stay tuned. The Cape's July launch schedule features a variety of SpaceX Starlink missions, with space fans anticipating target dates for NASA's SpaceX Crew-11 mission, United Launch Alliance's USSF-106 national security mission and Blue Origin's next New Glenn rocket liftoff. Following are the latest missions coming up from the Cape. All launches are listed in Eastern Standard Time. But be aware: Dates and times routinely change for a wide variety of reasons. For the latest mission updates and space news, visit For questions or comments, email FLORIDA TODAY Space Reporter Rick Neale at Rneale@ Cape Canaveral: Rocket launches in Florida: Here's an updating list of all 2025 missions from Cape Canaveral Though SpaceX has yet to announce this mission, the Space Coast Office of Tourism indicates a Starlink launch from Cape Canaveral Space Force Station. Mission: A SpaceX Falcon 9 will launch the next batch of Starlink internet satellites into low-Earth orbit. Launch window: 1:48 a.m. Trajectory: Northeast. Location: Space Launch Complex 40 Live coverage: Starts 90 minutes before liftoff at Mission: NASA and SpaceX will team up to send four crew members for a long-duration stay aboard the International Space Station. Launch: TBA. Location: TBA. Live FLORIDA TODAY Space Team coverage: Starts two hours before liftoff at Mission: Equipped with four solid rocket boosters, ULA's third Vulcan rocket will take flight on the Space Force's USSF-106 national security mission into geosynchronous orbit more than 22,000 miles above Earth. Launch: TBA. Location: Launch Complex 41 at Cape Canaveral Space Force Station. Sonic booms: No. Live FLORIDA TODAY Space Team coverage: Starts two hours before liftoff at Mission: Blue Origin will launch its second powerhouse New Glenn rocket from Cape Canaveral Space Force Station. Launch window: TBA. Location: Launch Complex 36. Live FLORIDA TODAY Space Team coverage: Starts two hours before liftoff at Mission: Sierra Space will launch its uncrewed Dream Chaser space plane atop a ULA Vulcan rocket from Cape Canaveral Space Force Station. Launch window: TBA. Location: Launch Complex 41. Live FLORIDA TODAY Space Team coverage: Starts two hours minutes before liftoff at For the latest news and launch schedule from Cape Canaveral Space Force Station and NASA's Kennedy Space Center, visit Another easy way: Click here to sign up for our weekly Space newsletter. Space is important to us and that's why we're working to bring you top coverage of the industry and Florida launches. Journalism like this takes time and resources. Please support it with a subscription here. This article originally appeared on Florida Today: Rocket launch schedule: July missions from Cape Canaveral, Florida

Rare object from beyond our solar system spotted zipping around Earth
Rare object from beyond our solar system spotted zipping around Earth

Washington Post

timean hour ago

  • Washington Post

Rare object from beyond our solar system spotted zipping around Earth

A newly discovered interstellar object is hurtling around us, only the third such interloper to be observed in our solar system. The object is not expected to pose an impact risk to Earth, but telescopes around the world have been able to detect the mystery visitor. The object — provisionally known as A11pl3Z — gained attention on Tuesday when it was spotted by telescopes for NASA's early warning system for asteroid impacts. Shortly after the discovery, amateur and professional astronomers looked through archival images and found it in earlier data from June. More than 100 observations have been made of the object, including from telescopes in Chile and Arizona. The object is traveling fast, speeding at our solar system at about 245,000 kilometers per hour relative to the sub, according to astronomer Josep M. Trigo Rodríguez. It is currently located just inside the orbit of Jupiter. The object — which will get a new name when it is approved and published by the Minor Planet Center — is currently 528 million kilometers from Earth (roughly the the distance it would take to travel from Earth to the moon 1,370 times.) It's uncertain if the object — appearing very faint at the moment — is a comet or asteroid at this time, according to scientists on Minor Planet mailing list. But the observations so far have helped track the object's journey, indicating it likely came from outside of the solar system from a thin galactic disk. The object could between 12 miles (20 kilometers) to 25 miles (40 kilometers) wide, according to various scientists. Marshall Eubanks, chief scientist at Space Initiatives Inc., estimated it could come close enough to Mars in early October to be observed by the Mars Reconnaissance Orbiter, although it would be only about 0.2 pixels wide. It is expected to reach its closest point to the sun later around October 29, reaching a distance about twice as far as Earth is from the sun. This is the third interstellar object to be observed in our solar system, with the other two found in the past decade. In 2017, scientists observed the first interstellar object known as Oumuamua, appearing rocky and cigar-shaped. Although it puzzled scientists because it didn't quite fit the definition of an asteroid or comet. In 2019, scientists saw our second interstellar visitor, comet 2I/Borisov. Part of the recent discoveries may be chalked up to more observations over time and a significantly improved capability to scan the skies, scientists said on the list serv. Such discoveries may become more commonplace with the surveys from the Vera Rubin Observatory, which has already found thousands of new asteroids in just 10 hours of operation. Compared to the other two previously found objects, A11pl3Z has a unique orbit. It has a very extreme hyperbolic trajectory through the solar system (or a high eccentricity) — meaning it won't be coming back to our solar system once it leaves. More observations will help scientists determine the object's path through our solar system, where it came from and if it's a comet. The object will appear brighter as it approaches Earth, but models show it will likely be on the other side of the sun. But, don't be bummed, there's probably another interstellar object waiting to be discovered in time.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store